Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RFA Treatment for Papillary Thyroid Microcarcinoma Cohort

NCT05189821 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05189821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05189821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RFA Treatment for Papillary Thyroid Microcarcinoma Cohort
Lead sponsor
Columbia University
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2021
Completion date
November 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papillary thyroid microcarcinoma